QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
QAIAx
4 other identifiers
interventional
1,000,000
1 country
1
Brief Summary
BRIEF SUMMARY A. "What is the purpose of this study?" This study will test whether the "AI City Hall Project" (QAIAx), a quantum artificial intelligence (AI) public health agency, can provide free or low-cost behavioral and mental health services inside self-contained, dome-enclosed communities called "Microcities". Researchers want to see if AI-managed public administration, AI humanoid robots, holoportation of human-figures via 'holo-suites' (e.g., AI-119 Kikkeri Holo-Suit; AI-119 Vulcan QM-Ware) and advanced AI mental-health tools can lower housing and care costs, improve mental health outcomes (e.g., particular ecosystems using AI tools among persons with one or more addiction disorders), and be financially sustainable for people on fixed incomes or public assistance. B. "What conditions does the study focus on?" The study focuses on adults with:
- Autism spectrum disorders (Asperger's, autism, ADHD, ASD)
- Substance use disorders (alcohol, opioids, marijuana, cocaine, MDMA/ecstasy, tobacco/nicotine)
- Psychiatric conditions (personality disorders, narcissism, gender dysphoria, eating disorders)
- Behavioral addictions (gambling, sex addiction) and related issues (sex offence history). C. "What does the study involve?" Eligible volunteers live in an omni AI-managed Microcity for up to 24 months. The community is housed in a geodesic dome that contains all daily necessities: housing, food, utilities, healthcare, and public services. Daily life is managed by an AI system (ISAC) and AI humanoid robots, with only occasional human oversight. Participants receive free mental-health treatment that may include AI-driven counselling, virtual-reality therapy (holo-suits), and non-invasive digital "attitude inoculation" protocols designed to reduce stress and addiction cravings. All participants also take AI-technology courses as a condition of enrolment. The study does not use any FDA-regulated drug, device, or biologic. \*\*Who can participate?\*\* You may be able to join if you:
- Are an adult (18 years or older)
- Have a diagnosis of one of the listed mental-health or addiction disorders
- Are referred by a licensed health professional (e.g., RN, NP, PhD, MD), a non-profit organisation (e.g., 501(c)(3), university, church), or a public agency (e.g., case manager, social worker, parole/probation officer, judge)
- Are willing to live in a closed, AI-managed community for up to one year and complete AI educational courses. Participants who are veterans, receive public assistance (e.g., VA disability, SSDI/SSI, Medicaid, Medicare), or are experiencing homelessness may be prioritised. \*\*Where is the study taking place?\*\* The study will be conducted at Microcity sites in the United States and internationally. The first administrative site is in Richmond, Virginia, USA. Additional sites are planned in partner nations, including tribal lands, military installations, and special economic zones. \*\*Who is sponsoring the study?\*\* The study is sponsored by \*\*Veterans Recovery Network Inc.\*\*, a non-profit organization, in collaboration with \*\*AI-119 Vulcan Project Research \& Educational Technology Co. (PRETCO)\*\* and an AI legal agency. The study is conducted under U.S. federal research and development authorities (28 U.S.C. §1498; 10 U.S.C. §129a) and is part of a Cooperative Research and Development Agreement (CRADA) with U.S. Special Operations Command (USSOCOM). This summary describes a planned clinical study. Not all details may be final. Information may change as the study progresses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
August 3, 2026
July 1, 2026
2.2 years
June 6, 2026
July 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Vulcan QAIAx v4.0x (Beta ISAC) for AI-119 and AI Wat (1498) patent series for Private, Public, and Military sectors (Change from Baseline in Participant Lifestyle Efficiency, Behavioral Stability, & Sovereign Resource Allocation via Vulcan QAIAx v4.0)
This comprehensive description bridges the clinical parameters of the AI-119 Vulcan SOF Program (an AGI/AI Ecosystems RDT\&E Program launched under the 119th U.S. Congress) and Veterans Recovery Network Program (VA-authorized program, est. 2020, Richmond VAMC) with the high-velocity public, private, and military administrative functions optimized by the AI-119 and AI Wat patent series under 28 U.S.C. § 1498 (Government Use of Patents), using a Omni-AI robotics among Holo-Suit, Quasi-Mind Ware (QM-Ware), Body-Ware, QAIA Humanoid (via "AI-Me" Hybrid AI Symbiote app). This primary outcome measures the definitive capacity of the Vulcan QAIAx v4.0x (Beta ISAC) autonomous platform to generate an efficient lifestyle, stabilize severe psychiatric and addiction disorders, and optimize administrative resource delivery across Private, Public, and Military sector frameworks. Utilizing a '90/10' hybrid workforce model (90% omni-AI Humanoid Workforce / 10% Human Auditor \& Administrator oversight).
Baseline enrollment, month 12, and month 24 (tracked monthly)
Change from Baseline in Participant Lifestyle Efficiency and Behavioral Stability Index (via QAIAx 4.0x Core Analytics)
The primary outcome directly track the core clinical and lifestyle stabilization of the veterans residing in the monitored Microcity ecosystem, measuring the effectiveness of the advanced AI/AGI tools. Total duration (measured in months vs. the traditional multi-year trajectories) and accuracy rate of AI-driven legal/health document processing, error corrections, and intake evaluations managed by the 90% AI Humanoid Workforce under human auditor ethical oversight under 'Kikkeri doctrine' to 'hire a million to skill a billion.'
Baseline enrollment, month 12, and month 24 (tracked monthly)
Secondary Outcomes (1)
Economic Sustainability and Housing Retention Cost Index under the Omni-AI Microcity Model
Baseline enrollment, month 12, and month 24 (tracked monthly)
Study Arms (11)
AI Public Health Central (Group 1)
EXPERIMENTALAI Public Health Central (Group 2)
EXPERIMENTALAI Public Health Central (Group 3)
EXPERIMENTALAI Public Health Central (Group 4)
EXPERIMENTALAI Public Health Central (Group 5)
EXPERIMENTALAI Public Health Central (Group 6)
EXPERIMENTALAI Public Health Central (Group 7)
EXPERIMENTALAI Public Health Central (Group 8)
EXPERIMENTALAI Public Health Central (Group 9)
EXPERIMENTALAI Public Health Central (Group 10)
EXPERIMENTALAI Public Health Central (Group 11)
EXPERIMENTALInterventions
QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT\&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation)
QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT\&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)
Eligibility Criteria
You may qualify if:
- Individuals aged 17 to 99 years old.
- Referral by a licensed health services professional (e.g., R.N., N.P., Ph.D., M.D.).
- Referral by a non-profit organization (e.g., 501c3, university, church).
- Referral by a public agency (e.g., case manager, social worker, parole/probation/PTS officer, judge).
You may not qualify if:
- \* Individuals under 17 or over 99 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Administrative Office
Richmond, Virginia, 23219, United States
Related Links
- AI-119 Vulcan Proposes Hybrid AI Governance System to Address Camp Lejeune Claims Backlog
- 'AI City Hall Project' Unveiled as Viable Hybrid AI Fix for CLJA Claims Crisis (Veterans First for America)
- Acknowledgment Notice (Veterans Recovery Network Program - Veterans Affairs Richmond VA.Gov Authorization\_Letter to Veterans Recovery\_Network Inc.)
- Mental Health Primary Care (MHPC) SUD Program Guidelines for Non-Treatment Seeking Veterans (9/22/2023)
- Cognitive Behavioral Therapy for Substance Use Disorders Among Veterans - Therapist Manual (2023, Rev. Ed.): VA framework formally links the protocol to the underlying clinical care continuum established by PMID: 24052453
- QAIAx TDC Model Code Statement - USPTO Patent App. 64105164 (ex rel. 'QAIAx' Clinical Trial (PRS NCT07661823)
- PROGRAM PRESS RELEASE (6-26-2026) QAIAx Clinical Trial Update
- New 'Digital DNA' project aims to keep human identity alive in humanoid robot after death A 40-sensor haptic suit could map a person's movements, vital signs, skills and identity into a "Digital DNA" profile
- QAIAx Proposes $1 Million 'Digital DNA' Plan to Replicate People for 500 Years
- 新"数字DNA"项目旨在让人死后以人形机器人延续其身份 知新了了 知新了了 2026-07-28 11:27 一套配备40个传感器的触觉服,能将人的动作、生命体征、技能和身份映射为一份"数字DNA"档案。
- Video Video Content QAIAx Microcities Clinical Trial (General Program Details)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2026
First Posted
June 22, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
August 3, 2026
Record last verified: 2026-07